| 标题 |
Utilization of extended-interval, fixed-dosing of durvalumab, every 4 weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation |
| 网址 | |
| DOI | |
| 其它 |
期刊:Future Oncology 作者:Reina Haque; Eric McGary; Mike Z. Yang; Raymond Liu; J. Marie Suga; et al 出版日期:2025 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)